首页> 外文期刊>African Journal of Microbiology Research >Detection of multidrug-resistant enterobacteria simultaneously producing extended-spectrum -lactamases of the PER and GES types isolated at Saint Camille Hospital Center, Ouagadougou, Burkina Faso
【24h】

Detection of multidrug-resistant enterobacteria simultaneously producing extended-spectrum -lactamases of the PER and GES types isolated at Saint Camille Hospital Center, Ouagadougou, Burkina Faso

机译:在布基纳法索瓦加杜古圣卡米尔医院中心分离出的同时产生PER和GES类型的广谱内酰胺酶的多重耐药肠杆菌的检测

获取原文
           

摘要

Resistance to a wide variety of common antibiotics is observed among clinical strains designated as extended-spectrum β-lactamase (ESBL) producers. These produce enzymatic proteins that effectively inactivate cephalosporins and aztreonam and are a serious global health problem that complicates treatment strategies. Many studies report a high prevalence of ESBL producers among Gram-negative bacilli. The purpose of this work was to identify resistance genes in enterobacterial strains. Gram-negative bacilli resistant to at least one third-generation cephalosporin, aztreonam or showing a synergy image between amoxicillin + clavulanic acid and a third generation cephalosporin were isolated during an antibiogram. Antibiotic resistance was detected for the following antibiotics: Ceftriaxone, Cefotaxime, Ceftazidime and Aztreonam. Classical polymerase chain reaction (PCR) analyzes of Pseudomonas extended resistance (PER) and Guiana extended-spectrum (GES) β-lactamase genes were performed using specific primers in 60 ESBL-producing isolates. Among 250 strains of Gram negative bacilli collected, 60 strains? (24%) showed resistance to antibiotics used. Stool samples are a major source of ESBL producers. The highest prevalence of resistant strains (35%) was observed in Escherichia coli. The GES and PER genes were simultaneously detected at a proportion of 13.33%. This study represents the first detection of PER and GES genes in multidrug-resistant enterobacteria in Burkina Faso.
机译:在指定为广谱β-内酰胺酶(ESBL)生产者的临床菌株中观察到对多种常见抗生素的耐药性。这些产生能有效灭活头孢菌素和氨曲南的酶蛋白,是严重的全球性健康问题,使治疗策略复杂化。许多研究报告ESBL生产者在革兰氏阴性杆菌中普遍存在。这项工作的目的是鉴定肠杆菌菌株中的抗性基因。在抗菌素谱图中分离出对至少一种第三代头孢菌素,氨曲南具有抗性或显示阿莫西林+克拉​​维酸和第三代头孢菌素之间具有协同作用图像的革兰氏阴性杆菌。检测到以下抗生素的抗生素耐药性:头孢曲松,头孢噻肟,头孢他啶和氨曲南。使用特异性引物在60株产生ESBL的菌株中进行了假单胞菌延伸抗性(PER)和圭亚那延伸光谱(GES)β-内酰胺酶基因的经典聚合酶链反应(PCR)分析。在收集到的250株革兰氏阴性菌中,有60株是革兰氏阴性菌。 (24%)对使用的抗生素有抗药性。粪便样本是ESBL生产商的主要来源。在大肠杆菌中观察到耐药菌株的最高流行率(35%)。同时检测到GES和PER基因的比例为13.33%。这项研究代表了在布基纳法索的多药耐药肠杆菌中首次检测到PER和GES基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号